Abstract:TNF-receptor-associated factors (TRAFs) are intracellular proteins that bind to the cytoplasmic portion of TNF receptors and mediate downstream signaling. The six known TRAF proteins play overlapping yet distinct roles in controlling immune responses as well as cellular processes such as activation of NF-κB and JNK signaling pathways. For example, CD40 binds to TRAF2, TRAF3 and TRAF6 to control B cell differentiation, proliferation and growth.1 In contrast, binding of lymphotoxin-β receptor (LTβR) to TRAF2 and TRAF5 propagates signals leading to activation of NF-κB,2 while binding to TRAF3 induces negative regulation of this pathway and leads to apoptosis in tumor cells.3,4 Binding recognition is mediated by specific contacts of a consensus recognition sequence in the partner with residues in a hydrophobic crevice on the TRAF molecule. Since each of these protein-protein interactions occurs within this same binding crevice, it appears that TRAF-mediated cellular mechanisms may be regulated, in part, by the level of expression or recruitment of the adaptor proteins or receptors that are competing for the crevice.The specific contacts of CD40, LTβR and BAFF-R have been defined in crystal structures of the complex with TRAF3.5–7 In addition, the downstream regulator TANK and the viral oncogenic protein LMP1 from the Epstein Barr virus also bind to the same TRAF crevice and these contacts have also been described crystallographically.8,9 Comparison of these five crystal structures has revealed that the recognition motifs in each of these proteins are accommodated in one TRAF3 binding crevice and that the binding interface is structurally and functionally adaptive.10 In this chapter, the molecular details of the interactions will be described and correlated with the functional implications for multiple TRAF3 roles in cellular regulation.

Crystal structures of FasL:DcR3 and LIGHT:DcR3 complexes reveal the molecular basis for the broad specificity of DcR3 (CCR5P.255)

Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3.

Mechanistic Basis for Functional Promiscuity in the TNF and TNF Receptor Superfamilies: Structure of the LIGHT:DcR3 Assembly.

Exploration and blockade of the decoy strategy: crystal structure of the LIGHT:DcR3 complex and rational design of DcR3 antagonists

The Diversity and Similarity of Transmembrane Trimerization of TNF Receptors

The Fas Ligand As a Cell Death Factor and Signal Transducer

Antigen Specificity Of Gamma Delta T Cells Depends Primarily On The Flanking Sequences Of Cdr3 Delta

Crystal Structure and Activation Mechanism of DR3 Death Domain.

Crystal Structure of the Ectodomain of Human FcαRI

X-ray Crystal Structure of TNF Ligand Family Member TL1A at 2.1Å

Protein-Protein Interactions in TRAF3

Regulation of FasL Expression: A SH3 Domain Containing Protein Family Involved in the Lysosomal Association of FasL

Cutting Edge: FcR-Like 6 Is an MHC Class II Receptor

Dimerization of Toll-like Receptor 3 (TLR3) Is Required for Ligand Binding

A Novel Approach to Generate LIGHT Mutants with Selectivity to Binding Partners (TECH2P.925)

Functional three-domain single-chain T-cell receptors

Identification of a novel type I cytokine receptor CRL2 preferentially expressed by human dendritic cells and activated monocytes

Death Decoy Receptor TR6/DcR3 Inhibits T Cell Chemotaxis in Vitro and in Vivo1

Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition

Ligand–receptor binding revealed by the TNF family member TALL-1

Structural similarity between Fc receptors and T cell receptors. Expression of the gamma-subunit of Fc epsilon RI in human T cells, natural killer cells and thymocytes.